| HOME >> BIOLOGY >> TECHNOLOGY |
Research and development 1,812 1,723
General and administrative 3,487 2,295
Total operating expenses 18,493 13,280
Income from operations 5,899 2,875
Interest income, net 801 505
Other income, net 553 56
Income before income taxes 7,253 3,436
Income tax provision 2,383 1,318
Net income $4,870 $2,118
Diluted net income per share $0.38 $0.17
Diluted weighted average shares outstanding 12,768 12,374
Basic net income per share $0.39 $0.19
Basic weighted average shares outstanding 12,471 11,345
Condensed Consolidated Balance Sheet
(In thousands)
March 31, December 31,
2008 2007
(unaudited)
Assets:
Cash, cash equivalents and marketable
securities $61,409 $86,097
Accounts receivable, net 30,906 24,124
Amounts due from related parties 22 8
Inventories 24,720 22,442
Deferred tax asset, current portion 4,568 4,161
Prepaid expenses and other current assets 4,362 4,425
Total current assets 125,987 141,257
Prop
'/>"/>
| SOURCE Cynosure, Inc. Copyright©2008 PR Newswire. All rights reserved |